BCYC (BCYC) Stock Price & Analysis
BCYC (BCYC) rose 0.00% to USD 3.87 as of July 25, 2026 at 04:25 UTC, according to Nexqual real-time market data.
BCYC last closed at USD 3.87; the session ranged USD 3.87–4.16 on volume of 570,522 shares. Market capitalization is —, with a 52-week range of USD 3.87–9.16 (NMS). Source: Nexqual, July 25, 2026 at 04:25 UTC.
Key Statistics (as of July 25, 2026 at 04:25 UTC)
| Price | USD 3.87 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 3.87 |
| Open | USD 3.87 |
| Day Range | USD 3.87 – 4.16 |
| 52-Week Range | USD 3.87 – 9.16 |
| Volume | 570,522 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (BCYC)
Nexqual's technical model rates BCYC "SELL" based on 2 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 04:25 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 34.09 (neutral) |
| vs SMA50 | Below (USD 4.26) |
| MACD | -0.05 (negative) |
From BCYC's Latest SEC 10-K Filing (filed 2026-03-17)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| IDYA | IDEAYA Biosciences, Inc. | USD 35.4 | ▲ 1.14% |
| CRNX | Crinetics Pharmaceuticals, Inc. | USD 83.73 | ▲ 0.01% |
| ARVN | Arvinas, Inc. | USD 8.03 | ▼ 2.78% |
| STRO | Sutro Biopharma, Inc. | USD 22.88 | ▼ 2.22% |
| STOK | Stoke Therapeutics, Inc. | USD 29.3 | ▲ 1.17% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 04:25 UTC. This page is informational and not investment advice.